dk-ah 268 has been researched along with loperamide in 1 studies
| Studies (dk-ah 268) | Trials (dk-ah 268) | Recent Studies (post-2010) (dk-ah 268) | Studies (loperamide) | Trials (loperamide) | Recent Studies (post-2010) (loperamide) |
|---|---|---|---|---|---|
| 15 | 0 | 4 | 1,358 | 196 | 488 |
| Protein | Taxonomy | dk-ah 268 (IC50) | loperamide (IC50) |
|---|---|---|---|
| Cocaine esterase | Homo sapiens (human) | 5.7 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3.005 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 2.5 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 9.27 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Histamine H2 receptor | Homo sapiens (human) | 3.081 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.202 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0014 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.337 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.896 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 3.125 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.105 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.033 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 0.239 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.628 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowlby, MR; Dunlop, J; Lee, YT; Mayer, S; Shan, QJ; Vasilyev, DV | 1 |
1 other study(ies) available for dk-ah 268 and loperamide
| Article | Year |
|---|---|
Novel pharmacological activity of loperamide and CP-339,818 on human HCN channels characterized with an automated electrophysiology assay.
Topics: Aminoquinolines; Antidiarrheals; Benzazepines; Cell Line; Chlorides; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Imines; Loperamide; Muscle Proteins; Potassium Channels; Pyrimidines; Quinolines | 2008 |